Merck to acquire rare diseases tech firm Acceleron Pharma for US$11.5 billion
USA – Merck has struck a US$11.5 billion deal to buy Acceleron Pharma to expand its growing...
Read MoreSelect Page
Oct 2, 2021
USA – Merck has struck a US$11.5 billion deal to buy Acceleron Pharma to expand its growing...
Read MoreOct 2, 2021
CONGO – The World Health Organization (WHO) is working with countries to scale up pathogen...
Read MoreOct 2, 2021
USA – An experimental antiviral pill developed by Merck & Co could halve the chances of...
Read MoreOct 2, 2021
SOUTH AFRICA – South Africa has launched a new COVID-19 vaccination drive to try and give...
Read More